MFN2 and atherosclerosis: These processes are controlled by mitochondria-associated small GTPases, including the mitochondria 2 fusion protein (mitofusin 2, Mfn2), which reduces proliferation and promotes apoptosis of smooth muscle cells, which makes this protein a potential target for the treatment of atherosclerosis (31).